LEE KELLER: Open Payments
NPI 1700191228 · SALEM, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 23 payments from 8 companies in 2025. Trend: 2023 $1,074 · 2024 $1,044 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $80 |
| Alkermes, Inc. | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $27 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: CAPLYTA, ARISTADA, COBENFY, REXULTI, Qelbree, HETLIOZ, VRAYLAR, FANAPT.
Industry payments across KY — which companies pay providers there.
